Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity
Kcr. Baynes et al., Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity, DIABETOLOG, 43(3), 2000, pp. 321-331
Aims/hypothesis. Phosphoinositide 3-kinase (PI 3K) plays a central part in
the mediation of insulin-stimulated glucose disposal. No genetic studies of
this enzyme in human syndromes of severe insulin resistance have been prev
iously reported.
Methods. Phosphoinositide 3-kinase p85 alpha regulatory subunit cDNA was ex
amined in 20 subjects with syndromes of severe insulin resistance by single
strand conformational polymorphism and restriction fragment length polymor
phism analyses. Insulin-stimulated phosphoinositide 3-kinase activity and r
ecruitment into phosphotyrosine complexes of variants of p85 alpha were stu
died in transiently transfected HEK293 cells. Phosphopeptide binding charac
teristics of wild-type and mutant p85 alpha-GST fusion proteins were examin
ed by surface plasmon resonance.
Results. The common p85 alpha variant, Met(326)Ile, was identified in 9 of
the 20 subjects. Functional studies of the Met(326)Ile variant showed it to
have equivalent insulin-stimulated lipid kinase activity and phosphotyrosi
ne recruitment as wild-type p85 alpha. A novel heterozygous mutation, Arg(4
09)Gln, was detected in one subject. Within the proband's family, carriers
of the mutation had a higher median fasting plasma insulin (218 pmol/l) com
pared with wild-type relatives (72 mol/l) (n = 8 subjects, p = 0.06). The A
rg409Gln p85 alpha subunit was associated with lower insulin-stimulated pho
sphoinositide 3-kinase activity compared with wild-type (mean reduction 15%
, p < 0.05, n = 5). The recruitment of Arg409Gln p85 alpha into phosphotyro
sine complexes was not significantly impaired. GST fusion proteins of wild-
type and mutant p85 alpha showed identical binding to phosphopeptides in su
rface plasmon resonance studies.
Conclusion/interpretation. Mutations in p85 alpha are uncommon in subjects
with syndromes of severe insulin resistance. The Met(326)Ile p85 alpha vari
ant appears to have no functional effect on the insulin-stimulated phosphoi
nositide 3-kinase activity. The impaired phosphoinositide 3-kinase activity
of the Arg(409)Gln mutant suggests that it could contribute to the insulin
resistance seen in this family.